Urolithiasis in patients with inflammatory bowel diseases

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F15%3A10314602" target="_blank" >RIV/00216208:11110/15:10314602 - isvavai.cz</a>

Výsledek na webu

<a href="http://www.prolekare.cz/linkout/56940" target="_blank" >http://www.prolekare.cz/linkout/56940</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.14735/amgh2015561" target="_blank" >10.14735/amgh2015561</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Urolithiasis in patients with inflammatory bowel diseases

Popis výsledku v původním jazyce

Inflammatory bowel diseases are typically accompanied by diarrhoea and malabsorption, both of which are predispos-ing factors for the formation of renal calculi. In patients who have not undergone bowel surgery the prevalence of urolithiasis has ranged from 1.5% to 5%, but after surgery stone prevalence can increase to up to 16%. Enteric hyperoxaluria is a frequent complication of inflammatory bowel diseases, ileal resection and Roux-En-Y gastric bypass and is a recognised cause of nephrolithiasis and nephrocalcinosis. The excess of oxalate is primarily excreted by the kidneys. Increased urinary excretion of oxalate results in urinary calcium oxalate supersaturation, leading to crystal aggregation, urolithiasis, and/ or nephrocalcinosis. Prevention ofoxalate lithiasis includes high fluid intake, prescription of oral citrate and magnesium, calcium supplement, nutritionally balanced low-oxalate low-fat diet and also biological manipulation of intestinal flora (Oxalobacter formigenes, Bi

Název v anglickém jazyce

Urolithiasis in patients with inflammatory bowel diseases

Popis výsledku anglicky

Inflammatory bowel diseases are typically accompanied by diarrhoea and malabsorption, both of which are predispos-ing factors for the formation of renal calculi. In patients who have not undergone bowel surgery the prevalence of urolithiasis has ranged from 1.5% to 5%, but after surgery stone prevalence can increase to up to 16%. Enteric hyperoxaluria is a frequent complication of inflammatory bowel diseases, ileal resection and Roux-En-Y gastric bypass and is a recognised cause of nephrolithiasis and nephrocalcinosis. The excess of oxalate is primarily excreted by the kidneys. Increased urinary excretion of oxalate results in urinary calcium oxalate supersaturation, leading to crystal aggregation, urolithiasis, and/ or nephrocalcinosis. Prevention ofoxalate lithiasis includes high fluid intake, prescription of oral citrate and magnesium, calcium supplement, nutritionally balanced low-oxalate low-fat diet and also biological manipulation of intestinal flora (Oxalobacter formigenes, Bi

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FE - Ostatní obory vnitřního lékařství

OECD FORD obor

—

Projekt

—

Návaznosti

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Rok uplatnění

2015

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Gastroenterologie a hepatologie

ISSN

1804-7874

e-ISSN

—

Svazek periodika

69

Číslo periodika v rámci svazku

6

Stát vydavatele periodika

CZ - Česká republika

Počet stran výsledku

9

Strana od-do

561-569

Kód UT WoS článku

—

EID výsledku v databázi Scopus

2-s2.0-84953292584